Skip directly to content

Study Safety Data

 

Inspired to Be Informed

 

Study Safety Data

Below are some of the common side effects of AROMASIN® (exemestane tablets) and tamoxifen reported during the Intergroup Exemestane Study (IES).

To learn more about the IES, please click here.

To see additional adverse events, please click here for full Prescribing Information.

For tips on what you can do if you experience a side effect listed, click here.

 
Women on AROMASIN (%)
Women on tamoxifen (%)

Hot flashes

21.2%

19.9%

Fatigue

16.1%

14.7%

Joint pain

14.6%

8.6%

Headache

13.1%

10.8%

Insomnia

12.4%

8.9%

Increased sweating

11.8%

10.4%

Many women think about their bone health. You should know that AROMASIN may reduce your bone mineral density (BMD) over time. The lower your BMD, the greater your risk of fracture and osteoporosis (weak and brittle bones) could be.

Some women who took part in the AROMASIN study developed osteoporosis (4.6% on AROMASIN vs 2.8% on tamoxifen). There was also a risk of fractures (4.2% on AROMASIN vs 3.1% on tamoxifen).